[
Almanza A, Carlesso A, Chintha C, Creedican S, Doultsinos D, Leuzzi B, Luis A, McCarthy N, Montibeller L, More S, Papaioannou A, Puschel F, Sassano ML, Skoko J, Agostinis P, de Belleroche J, Eriksson LA, Fulda S, Gorman AM, Healy S, Kozlov A, Munoz-Pinedo C, Rehm M, Chevet E, Samali A. Endoplasmic reticulum stress signalling - from basic mechanisms to clinical applications. FEBS J 286, 241–278, 2019.
]Search in Google Scholar
[
Auf G, Jabouille A, Guerit S, Pineau R, Delugin M, Bouchecareilh M, Favereaux A, Maitre M, Gaiser T, von Deimling A, Czabanka M, Vajkoczy P, Chevet E, Bikfalvi A, Moenner M. A shift from an angiogenic to invasive phenotype induced in malignant glioma by inhibition of the unfolded protein response sensor IRE1. Proc Natl Acad Sci USA 107, 15553–15558, 2010.
]Search in Google Scholar
[
Auf G, Jabouille A, Delugin M, Guerit S, Pineau R, North S, Platonova N, Maitre M, Favereaux A, Vajkoczy P, Seno M, Bikfalvi A, Minchenko D, Minchenko O, Moenner M. High epiregulin expression in human U87 glioma cells relies on IRE1alpha and promotes autocrine growth through EGF receptor. BMC Cancer 13, 597, 2013.
]Search in Google Scholar
[
Avril T, Vauleon E, Chevet E. Endoplasmic reticulum stress signaling and chemotherapy resistance in solid cancers. Oncogenesis 6, e373, 2017.
]Search in Google Scholar
[
Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massague J. Genes that mediate breast cancer metastasis to the brain. Nature 459, 1005–1009, 2009.
]Search in Google Scholar
[
Chevet E, Hetz C, Samali A. Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis. Cancer Discov 5, 586–597, 2015.
]Search in Google Scholar
[
Ediriweera MK, Jayasena S. The role of reprogrammed glucose metabolism in cancer. Metabolites 13, 345, 2023.
]Search in Google Scholar
[
Guan R, Peng L, Wang D, He H, Wang D, Zhang R, Wang H, Hao H, Zhang J, Song H, Sui S, Meng X, Cui X, Bai J, Sun W, Fu S, Yu J. Decreased TOB1 expression and increased phosphorylation of nuclear TOB1 promotes gastric cancer. Oncotarget 8, 75243–75253, 2017.
]Search in Google Scholar
[
Guo H, Zhang R, Afrifa J, Wang Y, Yu J. Decreased expression levels of DAL-1 and TOB1 are associated with clinico-pathological features and poor prognosis in gastric cancer. Pathol Res Pract 215, 152403, 2019.
]Search in Google Scholar
[
Hetz C, Zhang K, Kaufman RJ. Mechanisms, regulation and functions of the unfolded protein response. Nat Rev Mol Cell Biol 21, 421–438, 2020.
]Search in Google Scholar
[
Logue SE, McGrath EP, Cleary P, Greene S, Mnich K, Almanza A, Chevet E, Dwyer RM, Oommen A, Legembre P, Godey F, Madden EC, Leuzzi B, Obacz J, Zeng Q, Patterson JB, Jager R, Gorman AM, Samali A. Inhibition of IRE1 RNase activity modulates the tumor cell secretome and enhances response to chemotherapy. Nat Commun 9, 3267, 2018.
]Search in Google Scholar
[
Minchenko A, Leshchinsky I, Opentanova I, Sang N, Srinivas V, Armstead V, Caro J. Hypoxia-inducible factor-1-mediated expression of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3) gene. Its possible role in the Warburg effect. J Biol Chem 277, 6183–6187, 2002.
]Search in Google Scholar
[
Minchenko DO, Tsymbal DO, Riabovol OO, Viletska YM, Lahanovska YO, Sliusar MY, Bezrodnyi BH, Minchenko OH. Hypoxic regulation of EDN1, EDNRA, EDNRB, and ECE1 gene expressions in IRE1 knockdown U87 glioma cells. Endocr Regul 53, 250–262, 2019.
]Search in Google Scholar
[
Minchenko DO, Khita OO, Tsymbal DO, Danilovskyi SV, Rudnytska OV, Halkin OV, Kryvdiuk IV, Smeshkova MV, Yakymchuk MM, Bezrodnyi BH, Minchenko OH. Expression of IDE and PITRM1 genes in IRE1 knockdown U87 glioma cells: effect of hypoxia and glucose deprivation. Endocr Regul 54, 183–195, 2020.
]Search in Google Scholar
[
Minchenko OH, Tsymbal DO, Khita OO, Minchenko DO. Inhibition of ERN1 signaling is important for the suppression of tumor growth. Clin Cancer Drugs 8, 27–38, 2021.
]Search in Google Scholar
[
Minchenko OH, Abramchuk AI, Khita OO, Sliusar MY, Viletska YM, Minchenko DO. Endoplasmic reticulum stress-dependent regulation of carboxypeptidase E expression in glioblastoma cells. Endocr Regul 58, 206–214, 2024a.
]Search in Google Scholar
[
Minchenko OH, Khita OO, Krasnytska DA, Viletska YM, Rudnytska OV, Hnatiuk OS, Minchenko DO. ERN1 knockdown affects the expression of TGIF1 and other homeobox genes in U87MG glioblastoma cells. Arch Biochem Biophys 758, 110073, 2024b.
]Search in Google Scholar
[
Minchenko OH, Sliusar MY, Khikhlo YP, Halkin OV, Viletska YM, Khita OO, Minchenko DO. Knockdown of ERN1 disturbs the expression of phosphoserine aminotransferase 1 and related genes in glioblastoma cells. Arch Biochem Biophys 759, 110104, 2024c.
]Search in Google Scholar
[
Papaioannou A, Chevet E. Driving cancer tumorigenesis and metastasis through UPR signaling. Curr Top Microbiol Immunol 414, 159–192, 2018.
]Search in Google Scholar
[
Park SH, Yoon SJ, Choi S, Jung J, Park JY, Park YH, Seo J, Lee J, Lee MS, Lee SJ, Son MY, Cho YL, Kim JS, Lee HJ, Jeong J, Kim DS, Park YJ. Particulate matter promotes cancer metastasis through increased HBEGF expression in macrophages. Exp Mol Med 54, 1901–1912, 2022.
]Search in Google Scholar
[
Pelizzari-Raymundo D, Doultsinos D, Pineau R, Sauzay C, Koutsandreas T, Langlais T, Carlesso A, Gkotsi E, Negroni L, Avril T, Chatziioannou A, Chevet E, Eriksson LA, Guillory X. A novel IRE1 kinase inhibitor for adjuvant glioblastoma treatment. iScience 26, 106687, 2023.
]Search in Google Scholar
[
Pelizzari-Raymundo D, Maltret V, Nivet M, Pineau R, Papaioannou A, Zhou X, Caradec F, Martin S, Le Gallo M, Avril T, Chevet E, Lafont E. IRE1 RNase controls CD95-mediated cell death. EMBO Rep 25, 1792–1813, 2024.
]Search in Google Scholar
[
Peng X, Ma L, Chen X, Tang F, Zong X. Inhibition of FBP1 expression by KMT5A through TWIST1 methylation is one of the mechanisms leading to chemoresistance in breast cancer. Oncol Rep 52, 110, 2024.
]Search in Google Scholar
[
Pires BRB, Binato R, Ferreira GM, Correa S, Du Rocher B, Bulzico D, Crocamo S, Dos Santos EC, Lima LG, Abdelhay E. Twist1 influences the expression of leading members of the IL-17 signaling pathway in HER2-positive breast cancer cells. Int J Mol Sci 22, 12144, 2021.
]Search in Google Scholar
[
Rudnytska OV, Khita OO, Minchenko DO, Tsymbal DO, Yefimova YV, Sliusar MY, Minchenko OH. The low doses of SWCNTs exhibit a genotoxic effect on the normal human astrocytes by disrupting the functional integrity of the genome. Curr Res Toxicol 2, 64–71, 2021.
]Search in Google Scholar
[
Sun KK, Zhong N, Yang Y, Zhao L, Jiao Y. Enhanced radiosensitivity of NSCLC cells by transducer of erbB2.1 (TOB1) through modulation of the MAPK/ERK pathway. Oncol Rep 29, 2385–2391, 2013.
]Search in Google Scholar
[
Wang D, Song H, Zhao T, Wang M, Wang Y, Yu L, Wang P, Yu J. Phosphorylation of TOB1 at T172 and S320 is critical for gastric cancer proliferation and progression. Am J Transl Res 11, 5227–5239, 2019.
]Search in Google Scholar
[
Wang R, Huang Z, Qian C, Wang M, Zheng Y, Jiang R, Yu C. LncRNA WEE2-AS1 promotes proliferation and inhibits apoptosis in triple negative breast cancer cells via regulating miR-32-5p/TOB1 axis. Biochem Biophys Res Commun 526, 1005–1012, 2020.
]Search in Google Scholar
[
Wang D, Li Y, Sui S, Cai M, Dong K, Wang P, Liang X, Fu S, Yu J. Involvement of TOB1 on autophagy in gastric cancer AGS cells via decreasing the activation of AKT/mTOR signaling pathway. PeerJ 10, e12904, 2022.
]Search in Google Scholar
[
Wu YX, Lin YS, Li SC, Yao X, Cheng M, Zhu L, Liu HY. microRNA-194 is increased in polycystic ovary syndrome granulosa cell and induce KGN cells apoptosis by direct targeting heparin-binding EGF-like growth factor. Reprod Biol Endocrinol 19, 170, 2021.
]Search in Google Scholar
[
Xiao W, Zheng S, Xie X, Li X, Zhang L, Yang A, Wang J, Tang H, Xie X. SOX2 promotes brain metastasis of breast cancer by upregulating the expression of FSCN1 and HBEGF. Mol Ther Oncolytics 17, 118–129, 2020.
]Search in Google Scholar
[
Xu T, Yin F, Shi K. TMEM158 functions as an oncogene and promotes lung adenocarcinoma progression through the PI3K/AKT pathway via interaction with TWIST1. Exp Cell Res 437, 114010, 2024.
]Search in Google Scholar
[
Zhang Y, Tang L, Liu H, Cheng Y. The multiple functions of HB-EGF in female reproduction and related cancer: Molecular mechanisms and targeting strategies. Reprod Sci 31, 2588–2603, 2024.
]Search in Google Scholar
[
Zhao Z, Rahman MA, Chen ZG, Shin DM. Multiple biological functions of Twist1 in various cancers. Oncotarget 8, 20380–20393, 2017.
]Search in Google Scholar
[
Zhao T, Meng W, Chin Y, Gao L, Yang X, Sun S, Pan X, He L. Identification of miR-25-3p as a tumor biomarker: Regulation of cellular functions via TOB1 in breast cancer. Mol Med Rep 23, 406, 2021.
]Search in Google Scholar
[
Zhou ZN, Sharma VP, Beaty BT, Roh-Johnson M, Peterson EA, Van Rooijen N, Kenny PA, Wiley HS, Condeelis JS, Segall JE. Autocrine HBEGF expression promotes breast cancer intravasation, metastasis and macrophage-independent invasion in vivo. Oncogene 33, 3784–3793, 2014.
]Search in Google Scholar
